Olmesartan and telmisartan comparably preserve pancreatic beta-cell mass with reduction of oxidative stress in db/db mice

Published on Mar 1, 2014in Diabetology international
· DOI :10.1007/S13340-013-0135-X
Nayumi Shigihara5
Estimated H-index: 5
(Juntendo University),
Toyoyoshi Uchida19
Estimated H-index: 19
(Juntendo University)
+ 4 AuthorsHirotaka Watada78
Estimated H-index: 78
(Juntendo University)
Several clinical studies have provided evidence that blockade of the renin–angiotensin system (RAS) prevents onset of type 2 diabetes. In mice models of type 2 diabetes, some angiotensin II type 1 receptor blockers (ARBs) reportedly protect against reduction of beta-cell mass. Although several ARBs are commercially available, the effect of these drugs on beta-cell mass has not been compared directly. The purpose of this study was to compare the protective effects on beta cell mass of olmesartan, an ARB with strong binding capacity to the angiotensin II type 1 receptor, and telmisartan, an ARB with partial peroxisome proliferator-activated receptor-γ (PPARγ) activity. Eight-week-old female db/db mice were treated with olmesartan medoxomil (3.0 mg/kg body weight/day), telmisartan (1.5 mg/kg body weight/day), or placebo for 6 weeks. This was followed by examination of glucose tolerance, insulin sensitivity, and islet morphology in each group. Random glucose level after treatment with the two ARBs was slightly, but significantly, lower than in the placebo group whereas glucose tolerance and insulin sensitivity were similar among the three groups. Beta-cell mass was higher and staining intensities for NAD(P)H oxidase components and markers of oxidative stress were lower in islets of the olmesartan and telmisartan-treated groups than in those of the placebo group. Our results reveal that olmesartan and telmisartan had comparable effects on reduction of beta-cell mass in db/db mice via their antioxidant effects.
📖 Papers frequently viewed together
1 Citations
1 Citations
73 Citations
#1Ruben Rodriguez (UCM: University of California, Merced)H-Index: 8
#2Jose A. Viscarra (UCM: University of California, Merced)H-Index: 13
Last. Rudy M. Ortiz (UCM: University of California, Merced)H-Index: 26
view all 6 authors...
Renin-angiotensin system blockade improves glucose intolerance and insulin resistance, which contribute to the development of metabolic syndrome. However, the contribution of impaired insulin secretion to the pathogenesis of metabolic syndrome is not well defined. To assess the contributions of angiotensin receptor type 1 (AT1) activation and high glucose intake on pancreatic function and their effects on insulin signaling in skeletal muscle and adipose tissue, an oral glucose tolerance test (oG...
46 CitationsSource
#1John J.V. McMurray (Glas.: University of Glasgow)H-Index: 197
#2Rury R. Holman (University of Oxford)H-Index: 116
Last. Robert M. Califf (Duke University)H-Index: 210
view all 54 authors...
BACKGROUND: It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance. METHODS: In this double-blind, randomized clinical trial with a 2-by-2 factorial design, we assigned 9306 patients with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors to receive valsartan (up to 160 mg daily) or placebo (and nateglinide or placebo) in addition to lifes...
514 CitationsSource
#1Yoshihiro Kiya (Fukuoka University)H-Index: 11
#2Shin-ichiro Miura (Cleveland Clinic)H-Index: 42
Last. Keijiro Saku (Fukuoka University)H-Index: 56
view all 6 authors...
We previously reported that the angiotensin II type 1 (AT1) receptor blocker (ARB) olmesartan has two important interactions to evoke inverse agonism (IA). We refer to these interactions as the “double-chain domain (DCD).” Since the clinical pharmacotherapeutic relevance of olmesartan is still unclear, we examined these effects in rats and humans. We analyzed the effects at an advanced stage of renal insufficiency in Dahl salt-sensitive hypertensive rats (Study 1). Rats were fed a high-salt diet...
15 CitationsSource
#1Yukie Saitoh (University of Miyazaki)H-Index: 6
#2W. Hongwei (University of Miyazaki)H-Index: 1
Last. Masamitsu Nakazato (University of Miyazaki)H-Index: 88
view all 5 authors...
Abstract Aim Angiotensin II receptor blockers (ARB) have been shown to lower insulin resistance in obese diabetic animal models and to reduce the risk of new-onset diabetes in hypertensive patients. In the present study, we studied whether telmisartan, an ARB with partial peroxisome proliferator-activated receptor-γ (PPARγ) activity, can exert a direct effect against fatty-acid-induced oxidative stress in pancreatic β-cells. Methods The effect of telmisartan on lipotoxicity was evaluated using m...
28 CitationsSource
#1Masanobu Kaihara (Okayama University)H-Index: 5
#2Yoshio Nakamura (Okayama University)H-Index: 12
Last. Hirofumi Makino (Okayama University)H-Index: 98
view all 7 authors...
We investigated the impact of olmesartan and temocapril on pancreatic islet beta-cells during the development of diabetes mellitus using Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats. Four-week-old male OLETF rats were fed standard chow (untreated:n5), or chow containing either 0.005% olmesartan(n5) or 0.01% temocapril (n5) until being sacrificed at 35 weeks of age. Pancreas sections were double-stained with anti-insulin and anti-glucagon antibodies. The percent areas of beta-cells, alpha-cells...
9 CitationsSource
#1Chie Ebato (Juntendo University)H-Index: 7
#2Toyoyoshi Uchida (Juntendo University)H-Index: 19
Last. Hirotaka Watada (Juntendo University)H-Index: 78
view all 13 authors...
Summary Autophagy is an evolutionarily conserved machinery for bulk degradation of cytoplasmic components. Here, we report upregulation of autophagosome formation in pancreatic beta cells in diabetic db/db and in nondiabetic high-fat-fed C57BL/6 mice. Free fatty acids (FFAs), which can cause peripheral insulin resistance associated with diabetes, induced autophagy in β cells. Genetic ablation of atg7 in β cells resulted in degeneration of islets and impaired glucose tolerance with reduced insuli...
555 CitationsSource
#1Masaki Mogi (Ehime University)H-Index: 51
#2Kana Tsukuda (Ehime University)H-Index: 24
Last. Masatsugu Horiuchi (Ehime University)H-Index: 82
view all 9 authors...
Abstract The metabolic syndrome is closely related to dietary habits and seems to be associated with impairment of cognitive function in humans. Angiotensin receptor blockers are widely used with the expectation of preventing cardiovascular events and stroke and potential amelioration of the metabolic syndrome. We examined the diet-induced changes of cognitive function in mice treated with a high-salt and high-cholesterol diet. C57BL/6J mice were fed a high-salt (2% NaCl in drinking water) and h...
38 CitationsSource
#1Guo-Xing Zhang (Kagawa University)H-Index: 20
#2Koji Ohmori (Kagawa University)H-Index: 26
Last. Shoji Kimura (Kagawa University)H-Index: 32
view all 7 authors...
Abstract Elevated activities of the sympathetic nerve and renin–angiotensin systems are common features of heart failure. This study was designed to investigate the roles of the AT1 receptor in cardiac hypertrophy and oxidative stress during excessive β-adrenoceptor stimulation using an AT1 receptor antagonist (ARB) and AT1a receptor-deficient (AT1aR −/− ) mice. Isoproterenol (ISO) was given to C57BL mice with or without ARB (olmesartan) treatment and to AT1aR −/− mice by a subcutaneously implan...
66 CitationsSource
#1Toyoyoshi Uchida (Juntendo University)H-Index: 19
#2Noseki Iwashita (Juntendo University)H-Index: 7
Last. Hirotaka Watada (Juntendo University)H-Index: 78
view all 12 authors...
Abstract Protein kinase C (PKC) is considered to modulate glucose-stimulated insulin secretion. Pancreatic β cells express multiple isoforms of PKCs; however, the role of each isoform in glucose-stimulated insulin secretion remains controversial. In this study we investigated the role of PKCδ, a major isoform expressed in pancreatic β cells on β cell function. Here, we showed that PKCδ null mice manifested glucose intolerance with impaired insulin secretion. Insulin tolerance test showed no decr...
64 CitationsSource
#1Shin-ichiro Miura (Fukuoka University)H-Index: 42
#2Masahiro Fujino (Fukuoka University)H-Index: 13
Last. Keijiro Saku (Fukuoka University)H-Index: 56
view all 13 authors...
Abstract To delineate the molecular mechanism underlying the inverse agonist activity of olmesartan, a potent angiotensin II type 1 (AT1) receptor antagonist, we performed binding affinity studies and an inositol phosphate production assay. Binding affinity of olmesartan and its related compounds to wild-type and mutant AT1 receptors demonstrated that interactions between olmesartan and Tyr113, Lys199, His256, and Gln257 in the AT1 receptor were important. The inositol phosphate production assay...
109 CitationsSource
Cited By3
#1Yan Wang (Shanxi Medical University)H-Index: 2
#2Jing-jing Xue (Shanxi Medical University)H-Index: 2
Last. De-Wu Han (Shanxi Medical University)H-Index: 2
view all 6 authors...
: Telmisartan, an angiotensin II receptor blocker, has been widely used for hypertension. It has also been reported to improve insulin sensitivity in animal models of obesity and diabetic patients by targeting to the peroxisome proliferator-activated receptor (PPAR)-γ. High glucose/high lipid (HG/HL)-induced apoptosis of pancreatic β-cells impairs its function of insulin secretion and is generally believed to be the key factor in the development of diabetes. In this study, we investigated whethe...
11 CitationsSource
#1Latha Ramalingam (TTU: Texas Tech University)H-Index: 16
#2Kalhara R. Menikdiwela (TTU: Texas Tech University)H-Index: 6
Last. Naima Moustaid-Moussa (TTU: Texas Tech University)H-Index: 45
view all 7 authors...
Abstract Obesity is a complex disease characterized by excessive expansion of adipose tissue and is an important risk factor for chronic diseases such as cardiovascular disorders, hypertension and type 2 diabetes. Moreover, obesity is a major contributor to inflammation and oxidative stress, all of which are key underlying causes for diabetes and insulin resistance. Specifically, adipose tissue secretes bioactives molecules such as inflammatory hormone angiotensin II, generated in the Renin Angi...
97 CitationsSource
#1Martin C. Michel (University of Mainz)H-Index: 67
#2Hans R. Brunner (UNIL: University of Lausanne)H-Index: 82
Last. Yong Huo (PKU: Peking University)H-Index: 1
view all 4 authors...
Abstract We have reviewed the effects of angiotensin II type 1 receptor antagonists (ARBs) in various animal models of hypertension, atherosclerosis, cardiac function, hypertrophy and fibrosis, glucose and lipid metabolism, and renal function and morphology. Those of azilsartan and telmisartan have been included comprehensively whereas those of other ARBs have been included systematically but without intention of completeness. ARBs as a class lower blood pressure in established hypertension and ...
30 CitationsSource